Industry Roadmap Offers Route To Flexible, Low-Cost Biopharmaceutical Manufacturing
Executive Summary
A biopharmaceutical industry consortium has released a roadmap to help the industry achieve the flexibility and cost reductions needed to deal with a changing business and manufacturing environment. The group is promoting the use of six enabling technologies.
You may also be interested in...
Biologics Consortium Plans Collaborative Approach To Rapid Methods Validation
A plan to develop a “best practices” guide on validating rapid analytical methods for biopharmaceuticals is in the works.
NIIMBL Issues Roadmaps For Advancing Gene Therapy, Vaccine And Antibody Drug Conjugate Manufacturing
A public/private manufacturing technology partnership has produced three roadmaps to help the biopharmaceutical industry navigate some of the regulatory and analytical hurdles in developing and manufacturing gene therapies, vaccines and antibody-drug conjugates. All three roadmaps cite a knowledge gap in the industry and the need for an adequately trained workforce.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”